Evidence map›Paper›PMID 42339084›Full record

ArticleFrontiers in endocrinology2026

Diabetes-related stigma among individuals with type 1 diabetes in Jazan, Saudi Arabia: sociodemographic and clinical correlates.

Husameldin Elsawi Khalafalla, Osama Albasheer, Fatima A Elfaki, Abdulrahman Hummadi, Yahia Solan, Rania Hassan, Norah Rajeh, Taif Solan, Huda Mohamed Haroun Adam, Stef Pj Kremers

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Husameldin Elsawi KhalafallaResearch Institute of Nutrition and Translational Research in Metabolism (NUTRIM), Department of Health Education and Promotion, Faculty of Health, Medicine & Life Sciences, Maastricht University, Maastricht, Netherlands.
Osama AlbasheerDepartment of Family and Community Medicine, Jazan University, Jazan, Saudi Arabia.
Fatima A ElfakiDepartment of Clinical Nutrition, College of Nursing and Health Sciences, Jazan University, Jazan, Saudi Arabia.
Abdulrahman HummadiAdult Endocrinology and Diabetes Department, Jazan Endocrinology & Diabetes Center, Ministry of Health, Jazan, Saudi Arabia.
Yahia SolanAdult Endocrinology and Diabetes Department, Jazan Endocrinology & Diabetes Center, Ministry of Health, Jazan, Saudi Arabia.
Rania HassanAdult Endocrinology and Diabetes Department, Jazan Endocrinology & Diabetes Center, Ministry of Health, Jazan, Saudi Arabia.
Norah RajehAdult Endocrinology and Diabetes Department, Jazan Endocrinology & Diabetes Center, Ministry of Health, Jazan, Saudi Arabia.
Taif SolanFaculty of Medicine Jazan University, Jazan, Saudi Arabia.
Huda Mohamed Haroun AdamFaculty of Medicine, University of Gezira, Medani, Sudan.
Stef Pj KremersResearch Institute of Nutrition and Translational Research in Metabolism (NUTRIM), Department of Health Education and Promotion, Faculty of Health, Medicine & Life Sciences, Maastricht University, Maastricht, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Diabetes-related stigma can negatively affect self-management, psychological well-being, and health outcomes among people living with diabetes; however, its correlates in Middle Eastern populations remain insufficiently explored. Type 1 diabetes (T1D) is highly prevalent in Saudi Arabia and imposes substantial clinical, emotional, and social burdens, including stigma that may interfere with optimal care. Limited evidence from the Eastern Mediterranean Region highlights the need for context-specific research. Objective: This study assessed the prevalence of stigma among adults with T1D in Jazan, Saudi Arabia, and examined associated sociodemographic and clinical factors. Methods: A cross-sectional survey was conducted among 299 adults attending the Endocrinology and Diabetes Centre. Participants completed a structured questionnaire on sociodemographic and clinical characteristics and the Arabic Diabetes Type 1 Stigma Assessment Scale (DSAS-1), covering Treated Differently, Blame and Judgment, and Identity Concerns domains. Items were rated on a five-point Likert scale. Associations were examined using Spearman correlations, Mann-Whitney U, and Kruskal-Wallis tests, and hierarchical linear regression with sociodemographic factors entered first and clinical variables added in the second model. Results: Participants had a mean age of 30.4 ± 13.4 years (range: 18-87 years); most were females (59.2%) and urban residents (52.8%). Problematic stigma was observed across DSAS-1 domains, particularly Treated Differently and overall stigma. Higher stigma was associated with more recent diagnosis, poorer glycemic control and with more frequent episodes of hypoglycemia, hyperglycemia, and ketoacidosis. Stigma was also more common among females, urban residents, unemployed participants, and those with lower income or education. Regression models showed that clinical factors substantially improved explained variance of stigma. Conclusion: Diabetes-related stigma is common among adults with T1D in Jazan and is closely linked to adverse glycemic outcomes and sociodemographic disadvantage. Integrating strategies that reduce stigma into routine T1D care, particularly for individuals with poor glycemic control or recent diagnosis, may improve psychosocial well-being and clinical outcomes overall.

Indexed as

Diabetes Mellitus, Type 1Social StigmaAdolescentAdultAgedAged, 80 and overCross-Sectional StudiesFemaleHumansMaleMiddle AgedSaudi ArabiaSociodemographic FactorsSurveys and QuestionnairesYoung Adultdiabetes-related stigmaDSAS-1 scaleEastern Mediterranean Regionglycemic controlsociodemographic factorstype 1 diabetes

Identifiers

PMID42339084
PMCPMC13283795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.